Related Experiment Video
Updated: Jul 15, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk
Deirdre K Tobias1,2, Alisa K Manning3,4,5, Jennifer Wessel6
1Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Clonal hematopoiesis of indeterminate potential (CHIP) increases type 2 diabetes risk. This aging-related condition involves mutations in blood stem cells, highlighting shared pathways with cardiovascular disease.
Area of Science:
- Genetics
- Gerontology
- Endocrinology
Background:
- Clonal hematopoiesis of indeterminate potential (CHIP) is an aging-related condition involving somatic mutations in hematopoietic stem cells.
- CHIP is linked to cardiovascular disease and mortality, but its association with incident type 2 diabetes (T2D) remains unclear.
Conclusions:
- CHIP is associated with a higher incidence of type 2 diabetes.
- The link between CHIP mutations and T2D suggests shared underlying aging-related biological pathways.
- Further research may elucidate the precise mechanisms connecting CHIP and T2D pathogenesis.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Multipotency of Hematopoietic Stem Cells
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Lineage Commitment
Diabetes: Symptoms, Diagnosis, and Complications

